Pimples, zits, spots ”“ acne. All of us have suffered from some sort of skin inflammation at some point in our lives. Whether a big pimple the day of the prom, blackheads the morning of a big interview or “maskne” from wearing masks for two years ”“ we all know the embarrassment, frustration and occasional pain that acne can cause. For 50 million people, acne is not just a one-time affliction; it is an ongoing struggle that until recently had few great solutions.
Treating acne can sometimes be challenging due to its various etiologies. One such factor is overproduction of sebum ”“ the oily substance on the skin, produced by sebaceous, or oil, glands. When sebum combines with dead skin cells and obstructs pores, it can result in an acne flare.
Until recently, it has proven quite difficult to treat these sebaceous glands safely and effectively. This is why I am so excited to be the first physician in Westchester County to offer my patients a game-changing acne treatment, AviClear, the first FDA-approved laser treatment for mild, moderate and severe acne. AviClear is safe for all skin types and tones, and it diminishes acne in only three, 30-minute sessions.
Acne is a skin condition that affects many individuals at some point in their lives. Regardless of the underlying cause or causes, including hormonal changes in preteens and teenagers, stress in adults, even menopause, acne has the potential to affect everyone ”“ physically and/or emotionally. As a dermatologist, I have seen countless patients seeking a treatment that will not only help minimize their current acne breakouts but also help make future breakouts shorter and milder. This is exactly what AviClear does.
AviClear is a first-of-its-kind laser that utilizes a 1726 nm wavelength to treat acne by selectively targeting and suppressing the oil glands. The device is equipped with exclusive AviCool sapphire contact skin cooling and sensory controls that regulate the skin”™s temperature during treatment to ensure a safe, comfortable experience.
During an AviClear treatment session, the laser heats up the oil glands, partially destroying them and reducing their size. This process decreases bacterial growth, blackheads, whiteheads and inflammation caused by overactive oil glands. By shrinking the oil glands, AviClear achieves impressive results without the side effects of oral medication. Following an AviClear treatment, patients notice a decrease in sebum production, leading to a reduction in the inflamed appearance of acne. In addition, the patient is able to bypass any concerning effects of oral or topical medications, and there is no need for urine or blood tests. After treatment, patients can resume their activities immediately.
Before introducing a new device to our patients at Spectrum Skin and Laser in Purchase, I consider various factors such as safety and effectiveness. What”™s remarkable about AviClear is that it satisfies both criteria, providing patients with a comfortable experience while also delivering significant clinical benefits. Published clinical studies have shown that 90% of patients experienced visible improvement, and 87% saw at least half of their acne “clear.” Patients with moderate and severe acne who were treated with AviClear had a 93% reduction in inflammatory acne lesions within the first six months of treatment. https://jamanetwork.com/journals/ jamadermatology/fullarticle/479093
Over time, acne treatment has advanced significantly with many topical and oral medication options available to our patients. However, until now, no non-topical, non-oral treatment existed that truly gets to the root of one of the causes of acne ”“ overactive sebaceous glands. I believe AviClear is unique in this regard and points towards a bright future in how we approach the treatment of acne.
Jeremy A. Brauer, M.D., is founding director of Spectrum Skin and Laser in Purchase. He is a board-certified dermatologist, with fellowship training in Mohs micrographic, laser and cosmetic surgery. Brauer graduated with highest distinction from Cornell University and was named a Merrill Presidential Scholar. He earned his medical degree from the University of Pennsylvania School of Medicine, completing a Doris Duke Charitable Foundation Clinical Research Fellowship and receiving the John Glick Prize for Translational Cancer Research.
Brauer trained in the Ronald O. Perelman Department of Dermatology at New York University Langone Medical Center, serving as chief resident in his final year of residency. Upon graduation, he was awarded the Morris Leider Award for Excellence in Dermatology. He then completed a two-year fellowship in Mohs micrographic surgery, laser surgery and clinical research at the Laser & Skin Surgery Center of New York.
For more, call 914-848-1212 or click here https://spectrumskinlaser.com.
